Drug Type Small molecule drug |
Synonyms INCB 81776, INCB-81776, INCB081776 + [1] |
Target |
Mechanism AXL inhibitors(AXL receptor tyrosine kinase inhibitors), MerTK inhibitors(Tyrosine-protein kinase Mer inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | US | 27 Aug 2018 | |
Advanced Malignant Solid Neoplasm | Phase 1 | DK | 27 Aug 2018 | |
Advanced Malignant Solid Neoplasm | Phase 1 | NL | 27 Aug 2018 | |
Advanced Malignant Solid Neoplasm | Phase 1 | NO | 27 Aug 2018 | |
Advanced Malignant Solid Neoplasm | Phase 1 | SE | 27 Aug 2018 | |
Solid tumor | Phase 1 | US | 27 Aug 2018 |